Rituxan (rituximab) - Roche
prednisone - Generic mfg.
methylprednisolone sodium succinate - Generic mfg.
Role of 18 F-FDG PET/CT in the Diagnostic Evaluation of a Hypermetabolic Pulmonary Artery lesion: A Case Report of IgG4-Related Disease Mimicking Malignancy (EANM 2026) - Sep 29, 2026 - Abstract #EP-1494; "Systemic treatment was initiated with intravenous methylprednisolone pulses, followed by oral prednisone with rapid tapering and subsequent rituximab therapy. IgG4-RD involving the pulmonary artery is an exceptionally rare condition that may closely mimic vascular malignancy. 18F-FDG PET/CT is essential for lesion characterization, detection of multisystem involvement, and guiding therapeutic strategy." 
Case report • Clinical • FDG PET • Cardiovascular • Celiac Disease • Fibrosis • Immunology • Inflammatory Arthritis • Lupus • Musculoskeletal Pain • Oncology • Pancreatitis • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases • Sarcoma • Solid Tumor • Systemic Lupus Erythematosus • Women's Health
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
K. Guichay Duran; B. Tagliatori Nogueira; C. Paniagua Correa; C. Galindo Fernández; A. Sicilia Tafalla; L. Castillejos Rodríguez; A. Herrero Muñoz; S. Perez Quiros; A. Ortega Valle; M. Alvares Moreno; M. De la Rubia Marcos; P. García Alonso; P. Nespral Torres
 
Sep 29, 2026
 
Prev Next